KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Times Interest Earned (2020 - 2025)

Alnylam Pharmaceuticals (ALNY) has disclosed Times Interest Earned for 6 consecutive years, with $2.01 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned rose 174.64% year-over-year to $2.01, compared with a TTM value of $2.18 through Dec 2025, up 275.23%, and an annual FY2025 reading of $1.99, up 259.23% over the prior year.
  • Times Interest Earned was $2.01 for Q4 2025 at Alnylam Pharmaceuticals, down from $8.29 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $8.29 in Q3 2025 and bottomed at -$7.65 in Q2 2023.
  • Average Times Interest Earned over 5 years is -$2.22, with a median of -$3.59 recorded in 2022.
  • The sharpest move saw Times Interest Earned plummeted 132.32% in 2024, then soared 470.48% in 2025.
  • Year by year, Times Interest Earned stood at -$5.28 in 2021, then fell by 19.31% to -$6.31 in 2022, then surged by 41.09% to -$3.71 in 2023, then rose by 27.35% to -$2.7 in 2024, then surged by 174.64% to $2.01 in 2025.
  • Business Quant data shows Times Interest Earned for ALNY at $2.01 in Q4 2025, $8.29 in Q3 2025, and -$0.26 in Q2 2025.